Submit your email to push it up the queue
Optum Infusion Services 305, LLC, a prominent player in the healthcare industry, is headquartered in the United States and operates extensively across various regions. Founded in recent years, the company has quickly established itself as a leader in providing high-quality infusion therapy services, catering to patients with complex medical needs. Specialising in home and outpatient infusion therapies, Optum Infusion Services offers a range of core products and services that are tailored to enhance patient care. Their unique approach combines advanced technology with personalised support, ensuring optimal treatment outcomes. With a strong market position, Optum Infusion Services has achieved notable milestones, including recognition for its commitment to patient safety and satisfaction. As a trusted provider, the company continues to innovate within the infusion services sector, making significant contributions to the healthcare landscape.
How does Optum Infusion Services 305, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Optum Infusion Services 305, LLC's score of 72 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Optum Infusion Services 305, LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The organisation is a current subsidiary of UnitedHealth Group Incorporated, which cascades its emissions data and climate commitments down to Optum Infusion Services. As part of its corporate family, Optum Infusion Services adheres to the climate initiatives set forth by UnitedHealth Group. This includes participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are aimed at reducing greenhouse gas emissions in line with global climate goals. However, specific reduction targets or achievements for Optum Infusion Services 305, LLC have not been disclosed. The absence of direct emissions data highlights the importance of the overarching commitments made by its parent company, which are expected to influence the subsidiary's climate strategies. As the organisation continues to align with industry standards, it remains focused on contributing to broader climate action efforts within the healthcare sector.
Access structured emissions data, company-specific emission factors, and source documents
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|
Scope 1 | 15,838,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 161,303,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | 146,373,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Optum Infusion Services 305, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.